SCHEMBL17170484

SCHEMBL17170484

c1ccc(-c2ccc3c(c2)c2cc4c(cc2n3-c2cccc(-c3nc(-c5ccccc5)nc(-c5ccccc5)n3)c2)Oc2ccccc2O4)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ ATM Q13315 2/20 0.31
▸ FAAH O00519 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ MGLL Q99685 1/20 0.31
▸ HPSE Q9Y251 2/20 0.31
▸ NR3C1 P04150 1/20 0.31
▸ AVPR1A P37288 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17170486 0.92 MEN1 (0.40) GRM5ALDH1A1MEN1MAPTHPGD
SCHEMBL18969166 0.92 L3MBTL1 (0.41) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL10057525 0.89 ALDH1A1 (0.39) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL19041680 0.89 ALDH1A1 (0.39) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL22763819 0.89 ALDH1A1 (0.39) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL17170312 0.88 KDM4E (0.38) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL19041638 0.87 ALDH1A1 (0.38) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL17228051 0.87 ATM (0.41) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL19041623 0.87 ALDH1A1 (0.38) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL15305632 0.87 ATM (0.39) GRM5ALDH1A1MEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM GRM5 3295/4885ALDH1A1 610/4885MEN1 2658/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG GRM5 2945/4885ALDH1A1 522/4885MEN1 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback